MODULATION OF RETINOIC ACID RECEPTOR GENE EXPRESSION AND THERAPEUTIC USES THEREOF

Details for Australian Patent Application No. 2002328226 (hide)

Owner ANGIOGENE INC. CENTRE HOSPITALIER UNIVERSITAIRE DE MONTREAL

Inventors PAPPAS, Jane, J.; BRADLEY, W., Edward, C.; LEVESQUE, Luc

Pub. Number AU-A-2002328226

PCT Number PCT/CA02/01430

PCT Pub. Number WO2003/025171

Priority 60/322,422 17.09.01 US

Filing date 17 September 2002

Wipo publication date 1 April 2003

International Classifications

C12N 015/11 Mutation or genetic engineering - DNA or RNA fragments

Event Publications

23 January 2003 Complete Application Filed

  Priority application(s): 60/322,422 17.09.01 US

5 June 2003 Application Open to Public Inspection

  Published as AU-A-2002328226

10 June 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002328227-HIGH ACCURACY TIMING AND JITTER MEASUREMENT SYSTEM AND METHODS

2002328225-NOVEL PURIFIED POLYPEPTIDES INVOLVED IN PROTEIN PROCESSING